These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19403910)

  • 1. Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.
    Malgarini RB; Pimpinella G
    N Engl J Med; 2009 Apr; 360(18):1907; author reply 1908. PubMed ID: 19403910
    [No Abstract]   [Full Text] [Related]  

  • 2. Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.
    Schildgen O
    N Engl J Med; 2009 Apr; 360(18):1907-8; author reply 1908. PubMed ID: 19408360
    [No Abstract]   [Full Text] [Related]  

  • 3. Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C.
    Rodriguez-Torres M; Jeffers LJ; Sheikh MY; Rossaro L; Ankoma-Sey V; Hamzeh FM; Martin P;
    N Engl J Med; 2009 Jan; 360(3):257-67. PubMed ID: 19144941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection.
    Rodriguez-Torres M; Lawitz E; Yangco B; Jeffers L; Han SH; Thuluvath PJ; Rustgi V; Harrison S; Ghalib R; Vierling JM; Luketic V; Zamor PJ; Ravendhran N; Morgan TR; Pearlman B; O'Brien C; Khallafi H; Pyrsopoulos N; Kong G; McPhee F; Yin PD; Hughes E; Treitel M
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):834-845. PubMed ID: 27740516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Hispanic or Asian ethnicity on the treatment outcomes of chronic hepatitis C: results from the WIN-R trial.
    Hu KQ; Freilich B; Brown RS; Brass C; Jacobson IM
    J Clin Gastroenterol; 2011 Sep; 45(8):720-6. PubMed ID: 21836471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites.
    Muir AJ; Bornstein JD; Killenberg PG;
    N Engl J Med; 2004 May; 350(22):2265-71. PubMed ID: 15163776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated interferon alfa and ribavirin for children with chronic hepatitis C.
    Rosen I; Kori M; Eshach Adiv O; Yerushalmi B; Zion N; Shaoul R
    World J Gastroenterol; 2013 Feb; 19(7):1098-103. PubMed ID: 23467199
    [TBL] [Abstract][Full Text] [Related]  

  • 8.  Hepatitis C viral kinetics in Latino patients: a comparison to African American and Caucasian patients.
    Rodríguez-Torres M; Burguera J; Hallman D; Rodríguez-Orengo J; Echeandia M
    Ann Hepatol; 2012; 11(4):450-63. PubMed ID: 22700626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic hepatitis C in blacks and non-Hispanic whites.
    Moriguchi H; Sato C
    N Engl J Med; 2004 Aug; 351(8):831-2; author reply 831-2. PubMed ID: 15320315
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population.
    Rodriguez-Torres M; Sulkowski MS; Chung RT; Hamzeh FM; Jensen DM
    J Viral Hepat; 2010 Feb; 17(2):139-47. PubMed ID: 19674282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1.
    Pijak MR; Gazdik F; Hrusovsky S
    Hepatology; 2004 Sep; 40(3):760-1; author reply 761. PubMed ID: 15349918
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of chronic hepatitis C in blacks and non-Hispanic whites.
    Aigner ES
    N Engl J Med; 2004 Aug; 351(8):831-2; author reply 831-2. PubMed ID: 15317901
    [No Abstract]   [Full Text] [Related]  

  • 13. Peginterferon alfa-2a and ribavirin for chronic hepatitis C genotype 1 infections in black patients: safety, tolerability and impact on sustained virologic response.
    Howell CD; Jeffers LS; Cassidy W; Reddy KR; Hu S; Lee JS
    J Viral Hepat; 2006 Jun; 13(6):371-6. PubMed ID: 16842439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic.
    Srivastava S; Bertagnolli M; Lewis JH
    J Natl Med Assoc; 2005 Dec; 97(12):1703-7. PubMed ID: 16396063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation.
    Hartwell D; Cooper K; Frampton GK; Baxter L; Loveman E
    Health Technol Assess; 2014 Oct; 18(65):i-xxii, 1-202. PubMed ID: 25350588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
    Hartwell D; Jones J; Baxter L; Shepherd J
    Health Technol Assess; 2011 Apr; 15(17):i-xii, 1-210. PubMed ID: 21473834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equally poor outcomes to pegylated interferon-based therapy in African Americans and Hispanics with chronic hepatitis C infection.
    Satapathy SK; Lingisetty CS; Proper S; Chaudhari S; Williams S
    J Clin Gastroenterol; 2010 Feb; 44(2):140-5. PubMed ID: 19826275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin.
    Rustgi VK; Esposito S; Hamzeh FM; Shiffman ML
    Aliment Pharmacol Ther; 2008 Mar; 27(5):433-40. PubMed ID: 18081737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.
    Méndez-Navarro J; Chirino RA; Corey KE; Gorospe EC; Zheng H; Morán S; Juarez JA; Chung RT; Dehesa-Violante M
    Dig Dis Sci; 2010 Sep; 55(9):2629-35. PubMed ID: 19960257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
    N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.